It’s not the how but the why

The question isn’t whether Medtronic has a problem, the question is just how big is this problem, can they fix it before serious damage is done or are they even prepared to acknowledge they have a problem at all. We say this as yesterday we finally spoke with Medtronic, more specifically we spoke with Alejandro Galindo VP & BU President, Intensive Insulin Management (who by the way acknowledged during the interview has a total of 5 yes 5 years in the diabetes world) and James Dabbs Vice President of Quality Assurance.

While Mr. Galindo and Mr. Dabbs attempted to . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.